Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Monte Rosa Therapeutics, Inc. GLUE

Set alert

Price alert · GLUE

All alert types
10.76 USD -0.11 -1.01%

At close

10.85 +0.09 +0.84%

Pre-market · Nov 2, 6:25 AM ET

Bid
10.74 × 1
Ask
10.75 × 2
10.45 Day range 11.13
9.68 52-week range 25.77
YTD
-31.38%
1 year
-17.29%
Open
10.85
Prev close
10.87
Mkt cap
917.97M
Vol
1.35M
Avg vol
1.31M
EPS
-1.75
P/E
0.00
Div yield
0.00%
More statistics
Low
10.45
High
11.13
Forward P/E
-6.37
Beta
1.50
Short ratio
17.13
Inst. own
116.10%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
15.55
200-d avg
18.27
1y target
28.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GLUE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.72 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -26.6×
FY 2019: -118×FY 2020: -25.8×FY 2021: -12.8×FY 2022: -3.3×FY 2023: -2.1×FY 2024: -7.1×FY 2025: -26.6×
FY 2019 5y median -7.1× FY 2025
P/S 8.3×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 6.8×FY 2025: 8.3×
FY 2019 5y median 0.0× FY 2025
P/B 4.4×
FY 2019: -76.7×FY 2020: -19.1×FY 2021: 2.7×FY 2022: 1.3×FY 2023: 1.6×FY 2024: 2.3×FY 2025: 4.4×
FY 2019 5y median 2.3× FY 2025
P/FCF -37.4×
FY 2019: -123×FY 2020: -35.2×FY 2021: -13.8×FY 2022: -3.4×FY 2023: -4.6×FY 2024: 13.5×FY 2025: -37.4×
FY 2019 5y median -4.6× FY 2025
EV/EBITDA -29.9×
FY 2019: -121×FY 2020: -34.9×FY 2021: -8.4×FY 2022: -3.5×FY 2023: -1.6×FY 2024: -5.3×FY 2025: -29.9×
FY 2019 5y median -5.3× FY 2025
EV/Sales 7.6×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 4.4×FY 2025: 7.6×
FY 2019 5y median 0.0× FY 2025
FCF Yield -2.7%
FY 2019: -0.8%FY 2020: -2.8%FY 2021: -7.3%FY 2022: -29.3%FY 2023: -21.6%FY 2024: 7.4%FY 2025: -2.7%
FY 2019 5y median -7.3% FY 2025

Profitability

Gross Margin 93.2%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 89.3%FY 2025: 93.2%
FY 2019 5y median 0.0% FY 2025
Operating Margin -43.8%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -107.3%FY 2025: -43.8%
FY 2019 5y median 0.0% FY 2025
Net Margin -31.2%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -96.1%FY 2025: -31.2%
FY 2019 5y median 0.0% FY 2025
ROE -16.6%
FY 2019: 66.0%FY 2020: 73.6%FY 2021: -21.3%FY 2022: -40.0%FY 2023: -75.5%FY 2024: -32.6%FY 2025: -16.6%
FY 2019 5y median -32.6% FY 2025
ROIC -13.6%
FY 2019: -105.9%FY 2020: -139.3%FY 2021: -20.8%FY 2022: -35.1%FY 2023: -55.1%FY 2024: -28.4%FY 2025: -13.6%
FY 2019 5y median -28.4% FY 2025
ROA -8.6%
FY 2019: -72.3%FY 2020: -72.7%FY 2021: -20.2%FY 2022: -31.7%FY 2023: -44.6%FY 2024: -16.6%FY 2025: -8.6%
FY 2019 5y median -20.2% FY 2025

Growth (YoY)

Revenue 63.5%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 63.5%
FY 2019 FY 2025
Operating Income 33.2%
FY 2019: 0.0%FY 2020: -250.4%FY 2021: -160.2%FY 2022: -54.2%FY 2023: -27.5%FY 2024: 43.4%FY 2025: 33.2%
FY 2019 FY 2025
EPS (diluted) 39.8%
FY 2019: 0.0%FY 2020: -355.6%FY 2021: -93.9%FY 2022: -44.7%FY 2023: -14.3%FY 2024: 62.7%FY 2025: 39.8%
FY 2019 FY 2025
Free Cash Flow -172.3%
FY 2019: 0.0%FY 2020: -249.9%FY 2021: -161.3%FY 2022: -52.5%FY 2023: 40.4%FY 2024: 160.5%FY 2025: -172.3%
FY 2019 FY 2025

Financial Health

Current Ratio 6.1×
FY 2019: 2.3×FY 2020: 1.5×FY 2021: 21.0×FY 2022: 10.8×FY 2023: 5.1×FY 2024: 2.4×FY 2025: 6.1×
FY 2019 5y median 6.1× FY 2025
Quick Ratio 6.1×
FY 2019: 2.3×FY 2020: 1.5×FY 2021: 21.0×FY 2022: 10.8×FY 2023: 5.1×FY 2024: 2.4×FY 2025: 6.1×
FY 2019 5y median 6.1× FY 2025
Debt / Equity 0.2×
FY 2019: -0.1×FY 2020: -1.4×FY 2021: 0.0×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.2×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA 2.9×
FY 2019: 0.7×FY 2020: -0.9×FY 2021: 4.8×FY 2022: 0.1×FY 2023: 0.6×FY 2024: 2.9×FY 2025: 2.9×
FY 2019 5y median 2.9× FY 2025
Interest Coverage 0.0×
FY 2019: -7994×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -29.9×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31